Higher magnesium intake linked to less arterial calcification

Claude AI: Yes - April 2026

Yes, the evidenc[e is quite compelling — across multiple lines of research, magnesium appears to significantly inhibit and even partially reverse arterial calcification. Here's the picture:

Human Observational Evidence

In the Framingham Heart Study of 2,695 participants free of known cardiovascular disease, higher magnesium intake was associated with significantly lower coronary artery calcification (CAC) and abdominal aortic calcification (AAC). Across quartiles from lowest to highest intake, the prevalence of any CAC dropped from 47% to 39%, and the trend for AAC was similar.

Proposed Mechanisms

Two leading hypotheses have emerged: first, magnesium may bind phosphate and delay calcium phosphate crystal growth in circulation, passively interfering with deposition in the vessel wall. Second, magnesium may actively regulate vascular smooth muscle cell transdifferentiation toward an osteogenic (bone-like) phenotype — a key step in calcification.

In vitro studies show magnesium inhibits the formation of both hydroxyapatite and pathogenic calciprotein particles, and limits the osteogenic differentiation of vascular smooth muscle cells in the arterial media layer.

Animal Studies — Including Reversal

In uremic rats with established vascular calcification, a high-magnesium diet not only halted progression but actually reversed it — aortic calcium content at day 28 on the high-Mg diet was significantly lower than at day 14, demonstrating regression of existing calcification. Notably, this protective effect was not entirely explained by phosphate binding — animals with similar serum phosphate levels still had less vascular calcium accumulation when fed higher magnesium diets.

Clinical Trial Evidence

A 2-year randomized controlled trial in CKD patients found that magnesium oxide supplementation was associated with a median CAC score change of 11.3% versus 39.5% in controls. The proportion of patients with rapid CAC progression (≥15% annualized increase) was 23.9% in the MgO group versus 62.0% in controls. The study was stopped early because the interim results were so favorable, though larger trials are still needed.

Synergy with Polyphenols

An in vitro study found that magnesium alone reduced high-phosphate-induced calcium deposition by ~38%, quercetin/curcumin/resveratrol together reduced it by ~43%, but the combination reduced it by an striking 93% — far greater than additive effects alone would predict.

Bottom Line

The evidence is strong at the mechanistic and animal level, and encouraging — though not yet definitive — in humans. The effect appears most robust in the context of kidney disease, where calcification risk is highest, but the Framingham data suggests the relationship holds in generally healthy people too. Given magnesium's wide safety margin at typical supplemental doses and its other cardiovascular benefits (blood pressure, arrhythmia, insulin sensitivity), this is one of the stronger cases for supplementation in people who are deficient or insufficient.


Related in VitaminDWiki